Methodology

Trust the gold standard of science

Molecular allergy diagnostics allows for flexible, reliable, and accurate profiling of your sensitisation status.

We work with an allergen panel comprised of 117 allergen extracts and 178 molecular allergens, which makes it the largest panel of molecular allergens on the IgE allergy testing market. The use of molecular allergens leads to a much more precise risk assessment (e.g., the risk of anaphylaxis in a patient), a complete resolution of possible cross-reactivites, indication for immunotherapy, as well as differentiated dietary recommendations.

So why do we use both allergen extracts AND molecular allergens? We use allergen extracts where molecular allergens are not yet well-characterised or redundant due to a high degree of cross-reactivity. In return, we use molecular allergens where allergen extracts are unstable. This combination assures the most accurate profiling of a patient’s sensitisation status.

Clinical research

As leaders in the field of immunodiagnostics, we continuously drive evolution in multiplex testing, with a special focus on type I allergies. A quarter of the staff behind the science of MADx is dedicated to research and evelopment. It is a team comprised of assay developers, biochemists, chemists, and molecular biologists. Needless to say, they are essential parts of our team.

We are part of an extensive academic collaboration network and are in constant conversation with the scientific communities from the Americas, Asia, Australia, and Europe. This mutually beneficial exchange ensures our ability to translate the newest findings in research directly into our products.

Our science-oriented philosophy gives us the edge over our competitors in the allergy and food intolerance testing market. We continuously work on developing new applications for our patented nano-bead technology to ensure that we stay ahead of the curve in terms of innovation and quality of our products.